The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II randomized trial for early-stage squamous cell carcinoma of the oropharynx: Radiotherapy versus trans-oral robotic surgery (ORATOR).
 
Anthony Charles Nichols
Research Funding - Novartis
 
Julie Theurer
No Relationships to Disclose
 
Eitan Prisman
No Relationships to Disclose
 
Nancy E Read
No Relationships to Disclose
 
Eric Berthelet
Honoraria - Genzyme; Genzyme
Research Funding - Eisai; Genzyme
 
Eric Tran
No Relationships to Disclose
 
Fung Kevin
No Relationships to Disclose
 
John R. de Almeida
No Relationships to Disclose
 
Andrew Hope
No Relationships to Disclose
 
David Paul Goldstein
Stock and Other Ownership Interests - CVS (I); Johnson & Johnson (I); Merck (I); Pfizer (I)
 
Michael Hier
No Relationships to Disclose
 
Khalil Sultanem
No Relationships to Disclose
 
John Yoo
No Relationships to Disclose
 
S. Danielle Macneil
No Relationships to Disclose
 
Eric Winquist
Honoraria - Amgen; Bayer; Eisai; Merck; Roche
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Medivation (Inst); Merck (Inst); Roche/Genentech (Inst); Sanofi (Inst)
 
Alex Hammond
No Relationships to Disclose
 
Varagur Venkatesan
No Relationships to Disclose
 
Sara Kuruvilla
No Relationships to Disclose
 
Libni Eapen
No Relationships to Disclose
 
David A. Palma
No Relationships to Disclose